Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Oral contraceptive studies show a need for caution with databases
| The first 150 words of the full text of this article appear below. |
Three months ago a paper in the BMJ analysed the incidence of venous thromboembolism before and after the warning from the UK Committee on Safety of Medicines about third generation oral contraceptives.1 Using computer records of general practitioners, Farmer et al found that the incidence among pill users had not dropped, and they concluded that their findings were not compatible with a doubling of risk in women using third generation contraceptives (compared with older preparations). Their paper received wide publicity because it called into question an emerging consensus about this issue.2
This week's BMJ contains another analysis of computer
records from British general practice, conducted by a group in Boston (p 1190).3 Jick et al found that, both before and after
the warning in October 1995, the risk of venous thromboembolism in women using third generation oral contraceptives was about twice that
in users of preparations containing levonorgestrel. Moreover, fewer
Read all Rapid Responses